Integrating Genetic and Transcriptomic Data to Identify Genes Underlying Obesity Risk Loci
Hanfei XuiD, Shreyash GuptaiD, Ian R. DinsmoreiD, Abbey Kollu, Anne Marie Cawley, Mohammad Yaser AnwariD, Hung‐Hsin CheniD, Lauren E. PettyiD, Sudha S. SeshadriiD, Mariaelisa GraffiD, Jennifer Elizabeth BelowiD, Jennifer A. BrodyiD, Geetha ChittooriD, Susan P. Fisher-Hoch, Nancy L. Heard‐CostaiD, Daniel A LevyiD, Honghuang LiniD, Ruth J. F. LoosiD, Joseph B. McCormickiD, Jerome I. RotteriD, Tooraj MirshahiiD, Christopher D. StilliD, Anita L. DeStefanoiD, L. Adrienne CupplesiD, Karen L. MohlkeiD, , Ching‐Ti LiuiD
Abstract
Genome-wide association studies (GWAS) have identified numerous body mass index (BMI) loci. However, most underlying mechanisms from risk locus to BMI remain unknown. Leveraging omics data through integrative analyses could provide more comprehensive views of biological pathways on BMI. We analyzed genotype and blood gene expression data in up to 5,619 samples from the Framingham Heart Study (FHS). Using 3,992 single nucleotide polymorphisms (SNPs) at 97 BMI loci and 20,692 transcripts within 1 Mb, we performed separate association analyses of transcript with BMI and SNP with transcript (PBMI and PSNP, respectively) and then a correlated meta-analysis between the full summary data sets (PMETA). We identified transcripts that met Bonferroni-corrected significance for each omic, were more significant in the correlated meta-analysis than each omic, and were at least nominally associated with BMI in FHS data. Among 308 significant SNP-transcript-BMI associations, we identified seven genes (NT5C2, GSTM3, SNAPC3, SPNS1, TMEM245, YPEL3, and ZNF646) in five association regions. Using an independent sample of blood gene expression data, we validated results for SNAPC3 and YPEL3. We tested for generalization of these associations in hypothalamus, nucleus accumbens, and liver and observed significant (PMETA<0.05 & PMETA<PSNP & PMETA<PBMI) results for YPEL3 in nucleus accumbens and NT5C2, SNAPC3, TMEM245, YPEL3, and ZNF646 in liver. The identified genes help link the genetic variation at obesity risk loci to biological mechanisms and health outcomes, thus translating GWAS findings to function.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 2.33
- Field percentile
- top 11%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Penetrance of polygenic obesity susceptibility loci across the body mass index distribution: an update on scaling effects.
Arkan Abadi, Akram Alyass, … David Meyre·bioRxiv·Nov 29, 2017
- Epigenomic and transcriptomic prioritization of candidate obesity-risk regulatory GWAS SNPs
Xiao Zhang, Tianying Li, … Melanie Ehrlich·International Journal of Molecular SciencesPeer-reviewed·Jan 23, 2022
- Discovery of novel obesity genes through cross-ancestry analysis
Deepro Banerjee, Santhosh Girirajan·medRxiv·Oct 13, 2024
- Multifaceted genome-wide study identifies novel regulatory loci for body mass index in Indians
INDICO, Anil Kumar Giri, … Dwaipayan Bharadwaj·Molecular Genetics and GenomicsPeer-reviewed·May 3, 2020
- Genome-wide analysis and polygenic prediction of clinical obesity and comparison with body mass index
Sohail Zahid, Seraj N. Grimes, … Alexis J. Battle·medRxiv·May 22, 2026
- Investigating shared genetic architecture between obesity and multiple sclerosis
Ruijie Zeng, Rui Jiang, … Hao Hui Chen·medRxiv·Dec 7, 2022